financetom
Business
financetom
/
Business
/
Grupo Aeroportuario del Sureste's December Passenger Traffic Rises 2.3%
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Grupo Aeroportuario del Sureste's December Passenger Traffic Rises 2.3%
Jan 6, 2025 2:26 PM

05:06 PM EST, 01/06/2025 (MT Newswires) -- Grupo Aeroportuario del Sureste (ASR) said late Monday that passenger traffic in December rose 2.3% to 6.7 million from a year earlier.

Passenger traffic rose more than 16% in Puerto Rico and gained about 15% in Colombia, while slumping 5.7% in Mexico, the airport operator said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Atkore Fiscal Q1 Adjusted Net Income, Net Sales Decline; Fiscal 2025 Outlook Lowered
Atkore Fiscal Q1 Adjusted Net Income, Net Sales Decline; Fiscal 2025 Outlook Lowered
Feb 4, 2025
06:54 AM EST, 02/04/2025 (MT Newswires) -- Atkore ( ATKR ) reported fiscal Q1 adjusted net income Tuesday of $1.63 per diluted share, down from $4.12 a year earlier. Analysts polled by FactSet expected $1.55. Net sales for the fiscal quarter ended Dec. 27 was $661.6 million, down from $798.5 million a year earlier. Analysts surveyed by FactSet expected $679.8...
PUDO to Issue Up to 4.6 Million Common Shares in Private Placement, Debt Settlement
PUDO to Issue Up to 4.6 Million Common Shares in Private Placement, Debt Settlement
Feb 4, 2025
06:50 AM EST, 02/04/2025 (MT Newswires) -- PUDO (PDO.CN), which gained 85% yesterday, late on Monday said it has launched a private placement and debt settlement for the issuance of up to 4.6 million common shares. The issuance will settle debt related to trade accounts payable of up to $400,000 owed to creditors in consideration for the issuance of up...
Pfizer beats profit estimates on heart disease drug, COVID vaccine sales
Pfizer beats profit estimates on heart disease drug, COVID vaccine sales
Feb 4, 2025
(Reuters) -U.S. drugmaker Pfizer beat Wall Street estimates for fourth-quarter profit on Tuesday, helped by strong sales of its heart disease drug and a smaller-than-feared drop in COVID vaccine sales. On an adjusted basis, the company earned 63 cents per share for the three months ended Dec. 31, compared with the average analyst estimate of 47 cents per share, according...
Insurance broker WTW beats Q4 profit estimates on robust product demand
Insurance broker WTW beats Q4 profit estimates on robust product demand
Feb 4, 2025
Feb 4 (Reuters) - Insurance broker Willis Towers Watson ( WTW ) beat Wall Street estimates for fourth-quarter profit on Tuesday, driven by a strong performance in its risk and brokerage business. Businesses increased spending on insurance products as they prioritized financial security to safeguard against risks, despite higher premium prices. Insurance brokers' commissions are tied to the premiums insurers...
Copyright 2023-2026 - www.financetom.com All Rights Reserved